Karpas Strategies’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,000
Closed -$688K 117
2019
Q4
$688K Hold
10,000
0.26% 68
2019
Q3
$735K Hold
10,000
0.3% 63
2019
Q2
$717K Hold
10,000
0.3% 65
2019
Q1
$685K Hold
10,000
0.29% 66
2018
Q4
$595K Hold
10,000
0.28% 67
2018
Q3
$670K Hold
10,000
0.28% 65
2018
Q2
$648K Hold
10,000
0.28% 66
2018
Q1
$717K Hold
10,000
0.31% 64
2017
Q4
$755K Hold
10,000
0.32% 60
2017
Q3
$729K Hold
10,000
0.32% 59
2017
Q2
$741K Hold
10,000
0.33% 56
2017
Q1
$732K Hold
10,000
0.33% 57
2016
Q4
$654K Hold
10,000
0.31% 61
2016
Q3
$741K Hold
10,000
0.36% 56
2016
Q2
$732K Hold
10,000
0.37% 57
2016
Q1
$707K Hold
10,000
0.37% 57
2015
Q4
$666K Hold
10,000
0.35% 57
2015
Q3
$635K Hold
10,000
0.35% 57
2015
Q2
$654K Hold
10,000
0.33% 57
2015
Q1
$693K Hold
10,000
0.34% 58
2014
Q4
$692K Hold
10,000
0.33% 58
2014
Q3
$652K Hold
10,000
0.33% 62
2014
Q2
$682K Hold
10,000
0.34% 61
2014
Q1
$649K Sell
10,000
-450
-4% -$28.4K 0.34% 62
2013
Q4
$681K Hold
10,450
0.38% 58
2013
Q3
$620K Hold
10,450
0.36% 60
2013
Q2
$599K Buy
+10,450
New +$620K 0.37% 60

Other funds holding CL

Karpas Strategies's CL Position: Q1 2020 in Review

Karpas Strategies sold out of Colgate-Palmolive (CL) in Q1 2020, closing a stake of 10,000 shares — an estimated $688K sold.

Karpas Strategies first reported a position in CL in Q2 2013 and held it in 27 quarters. The position peaked at $755K in Q4 2017. 1,494 funds tracked by Wall St. Rank hold CL as of Q1 2020.

  • Karpas Strategies reported no remaining Colgate-Palmolive position as of Q1 2020 after selling out during the quarter.
  • Karpas Strategies sold 10,000 Colgate-Palmolive shares in Q1 2020, an estimated $688K.
  • Karpas Strategies first reported a position in Colgate-Palmolive in Q2 2013 and held it in 27 quarters.
  • Karpas Strategies's Colgate-Palmolive position peaked at $755K in Q4 2017.
  • 1,494 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2020.

Based on Karpas Strategies's 13F filing for Q1 2020, filed 22 Apr 2020.